AxoGen Current Ratio 2010-2025 | AXGN
AxoGen current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| AxoGen Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.09B | $0.02B | 4.28 |
| 2024-12-31 | $0.10B | $0.03B | 3.24 |
| 2024-09-30 | $0.09B | $0.02B | 3.75 |
| 2024-06-30 | $0.08B | $0.02B | 3.51 |
| 2024-03-31 | $0.08B | $0.02B | 3.43 |
| 2023-12-31 | $0.09B | $0.03B | 2.89 |
| 2023-09-30 | $0.09B | $0.03B | 3.28 |
| 2023-06-30 | $0.09B | $0.02B | 3.60 |
| 2023-03-31 | $0.09B | $0.02B | 4.18 |
| 2022-12-31 | $0.10B | $0.02B | 4.13 |
| 2022-09-30 | $0.10B | $0.02B | 4.35 |
| 2022-06-30 | $0.11B | $0.02B | 4.52 |
| 2022-03-31 | $0.11B | $0.02B | 4.90 |
| 2021-12-31 | $0.13B | $0.02B | 5.23 |
| 2021-09-30 | $0.14B | $0.02B | 5.78 |
| 2021-06-30 | $0.14B | $0.02B | 6.56 |
| 2021-03-31 | $0.14B | $0.02B | 6.07 |
| 2020-12-31 | $0.15B | $0.02B | 6.36 |
| 2020-09-30 | $0.14B | $0.02B | 7.45 |
| 2020-06-30 | $0.14B | $0.01B | 10.00 |
| 2020-03-31 | $0.12B | $0.02B | 6.18 |
| 2019-12-31 | $0.14B | $0.02B | 6.47 |
| 2019-09-30 | $0.14B | $0.02B | 8.20 |
| 2019-06-30 | $0.14B | $0.02B | 8.70 |
| 2019-03-31 | $0.15B | $0.02B | 8.83 |
| 2018-12-31 | $0.15B | $0.01B | 11.57 |
| 2018-09-30 | $0.15B | $0.01B | 12.72 |
| 2018-06-30 | $0.16B | $0.01B | 15.92 |
| 2018-03-31 | $0.05B | $0.02B | 3.32 |
| 2017-12-31 | $0.06B | $0.01B | 4.06 |
| 2017-09-30 | $0.04B | $0.01B | 3.55 |
| 2017-06-30 | $0.04B | $0.01B | 3.67 |
| 2017-03-31 | $0.04B | $0.01B | 3.82 |
| 2016-12-31 | $0.04B | $0.01B | 3.97 |
| 2016-09-30 | $0.03B | $0.01B | 6.24 |
| 2016-06-30 | $0.03B | $0.00B | 7.58 |
| 2016-03-31 | $0.03B | $0.00B | 8.36 |
| 2015-12-31 | $0.04B | $0.00B | 9.45 |
| 2015-09-30 | $0.04B | $0.00B | 9.41 |
| 2015-06-30 | $0.02B | $0.00B | 6.79 |
| 2015-03-31 | $0.03B | $0.00B | 7.57 |
| 2014-12-31 | $0.01B | $0.00B | 5.89 |
| 2014-09-30 | $0.02B | $0.00B | 8.85 |
| 2014-06-30 | $0.02B | $0.00B | 8.99 |
| 2014-03-31 | $0.02B | $0.00B | 11.67 |
| 2013-12-31 | $0.03B | $0.00B | 12.23 |
| 2013-09-30 | $0.03B | $0.00B | 21.23 |
| 2013-06-30 | $0.01B | $0.00B | 8.70 |
| 2013-03-31 | $0.02B | $0.00B | 11.24 |
| 2012-12-31 | $0.02B | $0.00B | 12.36 |
| 2012-09-30 | $0.01B | $0.00B | 2.18 |
| 2012-06-30 | $0.01B | $0.00B | 2.64 |
| 2012-03-31 | $0.01B | $0.00B | 3.63 |
| 2011-12-31 | $0.01B | $0.00B | 5.39 |
| 2011-09-30 | $0.01B | $0.00B | 7.89 |
| 2011-06-30 | $0.01B | $0.00B | 15.69 |
| 2011-03-31 | $0.01B | $0.00B | 48.69 |
| 2010-12-31 | $0.01B | $0.01B | 0.56 |
| 2010-09-30 | $0.01B | $0.00B | 73.38 |
| 2010-06-30 | $0.01B | $0.00B | 78.55 |
| 2010-03-31 | $0.01B | $0.00B | 24.13 |
| 2009-12-31 | $0.02B | $0.01B | 2.92 |
| 2009-09-30 | $0.00B | $0.00B | 1.55 |
| 2009-06-30 | $0.00B | $0.00B | 1.66 |
| 2009-03-31 | $0.00B | $0.00B | 1.49 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.457B | $0.187B |
| AxoGen, Inc. engages in developing and marketing surgical solutions for peripheral nerves. The company's portfolio of products includes Avance Nerve Graft(R), AxoGuard Nerve Connector(R), AxoGuard Nerve Protector(R), Avive Soft Tissue Membrane(R), AcroVal Neurosensory & Motor Testing System(R) and AxoTouch Two-Point Discriminator(R). It operates primarily in the United States, Canada, the United Kingdom, and other European and international countries. AxoGen Inc., formerly known as AxoGen Corp., is based in FL, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.869B | 80.53 |
| Thermo Fisher Scientific (TMO) | United States | $156.785B | 18.97 |
| Edwards Lifesciences (EW) | United States | $44.517B | 29.19 |
| Alcon (ALC) | Switzerland | $43.958B | 29.71 |
| IDEXX Laboratories (IDXX) | United States | $42.376B | 48.70 |
| DexCom (DXCM) | United States | $32.486B | 50.21 |
| IQVIA Holdings (IQV) | United States | $27.529B | 15.42 |
| Mettler-Toledo (MTD) | United States | $24.694B | 29.37 |
| STERIS (STE) | Ireland | $23.846B | 26.26 |
| Waters (WAT) | United States | $20.803B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.964B | 0.00 |
| Hologic (HOLX) | United States | $14.534B | 15.79 |
| Sysmex ADR (SSMXY) | Japan | $10.991B | 31.18 |
| Penumbra (PEN) | United States | $9.813B | 77.02 |
| Masimo (MASI) | United States | $8.965B | 33.07 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.395B | 8.91 |
| TransMedics (TMDX) | United States | $4.838B | 105.18 |
| Integer Holdings (ITGR) | United States | $4.143B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.384B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.543B | 15.14 |
| Nihon Kohden (NHNKY) | Japan | $2.185B | 25.06 |
| Veracyte (VCYT) | United States | $2.090B | 29.33 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.662B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.393B | 0.00 |
| Artivion (AORT) | United States | $1.227B | 114.96 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| Beta Bionics (BBNX) | United States | $0.845B | 0.00 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| IRadimed (IRMD) | United States | $0.757B | 38.43 |
| RxSight (RXST) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 8.90 |
| Mesa Laboratories (MLAB) | United States | $0.545B | 12.77 |
| Delcath Systems (DCTH) | United States | $0.545B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.528B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.354B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.343B | 9.12 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| 908 Devices (MASS) | United States | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.231B | 14.01 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| CVRx (CVRX) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 49.70 |
| EnVVeno Medical (NVNO) | United States | $0.077B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.54 |